Silencing of farnesoid X receptor in human colon cancer by epigenetic mechanisms is associated with cancer progression.

被引：0
|
作者：
Thomas, Ann M. [1 ]
Zhan, Le [2 ]
Izzo, Julie [1 ]
Maru, Dipen [1 ]
Shureiqi, Imad [1 ]
Baladandayuthapani, Veera [1 ]
Liang, Han [1 ]
Guo, Grace L. [3 ]
Powis, Garth [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Kansas Med Ctr, Kansas City, KS USA
[3] Rutgers State Univ, Piscataway, NJ USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3561
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Epigenetic silencing of the tumor suppressor klotho in human breast cancer
    Rubinek, Tami
    Shulman, Michal
    Israeli, Shira
    Bose, Shikha
    Avraham, Ayelet
    Zundelevich, Adi
    Evron, Ella
    Gal-Yam, Einav Nili
    Kaufman, Bella
    Wolf, Ido
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 649 - 657
  • [42] Epigenetic silencing of the tumor suppressor klotho in human breast cancer
    Tami Rubinek
    Michal Shulman
    Shira Israeli
    Shikha Bose
    Ayelet Avraham
    Adi Zundelevich
    Ella Evron
    Einav Nili Gal-Yam
    Bella Kaufman
    Ido Wolf
    Breast Cancer Research and Treatment, 2012, 133 : 649 - 657
  • [43] Dysregulation of selected annexin family proteins is associated with prostate cancer progression.
    Xin, W
    Chinnaiyan, AM
    Pienta, KJ
    Dhanasekaran, SM
    Ingold, C
    Rubin, MA
    JOURNAL OF UROLOGY, 2002, 167 (04): : 173 - 173
  • [44] Epigenetic signature associated with thyroid cancer progression and metastasis
    Zhang, Hong
    Duan, Hong-Liang
    Wang, Sen
    Liu, Yang
    Ding, Guo-Nan
    Lin, Rui-Xin
    SEMINARS IN CANCER BIOLOGY, 2022, 83 : 261 - 268
  • [45] Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma
    Wenbiao Chen
    Donge Tang
    Dongxin Tang
    Yong Dai
    Cell Death & Disease, 11
  • [46] Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma
    Chen, Wenbiao
    Tang, Donge
    Tang, Dongxin
    Dai, Yong
    CELL DEATH & DISEASE, 2020, 11 (10)
  • [47] Smad Signaling Is Required to Maintain Epigenetic Silencing during Breast Cancer Progression
    Papageorgis, Panagiotis
    Lambert, Arthur W.
    Ozturk, Sait
    Gao, Fangming
    Pan, Hongjie
    Manne, Upender
    Alekseyev, Yuriy O.
    Thiagalingam, Arunthathi
    Abdolmaleky, Hamid M.
    Lenburg, Marc
    Thiagalingam, Sam
    CANCER RESEARCH, 2010, 70 (03) : 968 - 978
  • [48] The role of the epigenetic regulator SATB2 in colon cancer progression
    Brennan, Donal J.
    Naicker, Kirsha
    Das, Sudipto
    Moran, Bruce
    Klinger, Rut
    Ponten, Fredrik
    Hewitt, Stephen
    Jirstrom, Karin
    Byrne, Annette T.
    O'Sullivan, Jacintha
    Gallagher, William M.
    O'Connor, Darran P.
    CANCER RESEARCH, 2019, 79 (13)
  • [49] The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
    Sun, Lulu
    Cai, Jie
    Gonzalez, Frank J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2021, 18 (05) : 335 - 347
  • [50] Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes
    Vrba, Lukas
    Futscher, Bernard Walter
    JOURNAL OF BREAST CANCER, 2017, 20 (02) : 198 - 202
12345